These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2161058)

  • 1. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of pipecuronium bromide during halothane or enflurane anesthesia--a comparison with pancuronium regarding the optimal dose and the effect of volatile anesthetics on neuromuscular blockade].
    Amaki Y; Yamamura H
    Masui; 1993 Jun; 42(6):876-82. PubMed ID: 8391589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of pipecuronium bromide.
    Larijani GE; Bartkowski RR; Azad SS; Seltzer JL; Weinberger MJ; Beach CA; Goldberg ME
    Anesth Analg; 1989 Jun; 68(6):734-9. PubMed ID: 2544118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of different doses of pipecuronium bromide during nitrous-oxide-fentanyl anaesthesia in adult surgical patients.
    Sanfilippo M; Fierro G; Vilardi V; Rosa G; De Gregorio AL; Gasparetto A
    Eur J Anaesthesiol; 1992 Jan; 9(1):49-53. PubMed ID: 1310464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.
    Kárpáti E; Biró K
    Arzneimittelforschung; 1980; 30(2a):346-57. PubMed ID: 6155921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations on the neuromuscular blocking action of pipecuronium in the dog.
    Jones RS
    Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children.
    Pittet JF; Tassonyi E; Morel DR; Gemperle G; Richter M; Rouge JC
    Anesthesiology; 1989 Aug; 71(2):210-3. PubMed ID: 2547325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of pipecuronium in infants and children during halothane anesthesia.
    Sarner JB; Brandom BW; Dong ML; Pickle D; Cook DR; Weinberger MJ
    Anesth Analg; 1990 Oct; 71(4):362-6. PubMed ID: 2169211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiration paralysing and circulatory effects of a new non-depolarizing relaxant, pipecurium bromide, in anaesthetized dogs.
    Pulay I; Alánt O; Darvas K; Weltner J; Zétény Z
    Arzneimittelforschung; 1980; 30(2a):358-60. PubMed ID: 6248078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulatory effects of pipecurium bromide during anaesthesia of patients with severe valvular and ischaemic heart diseases.
    Barankay A
    Arzneimittelforschung; 1980; 30(2a):386-9. PubMed ID: 6248086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopharmacology of Arduan].
    Mészáros C
    Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacologic effects of pipecuronium bromide (Arduan)].
    Kárpáti E; Bíró K
    Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the onset, spontaneous recovery and train of four fade of the clinical neuromuscular block produced by pancuronium and pipecuronium.
    Gyermek L; Cantley EM
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):600-5. PubMed ID: 7874374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
    Yajima C; Sugai N; Hanaoka K; Numata K; Yamamoto K; Kushida Y; Murakami S; Yamamura H
    Masui; 1990 Jul; 39(7):882-9. PubMed ID: 1976829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.